Clinical trial NCT01298739: Asthma Control Study 2011
Official title: Asthma Control Study 2011
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Asthma Control Level
Keywords: asthma control level , ACQ
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2011-02-18
Enrollment: 1524
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Asthmatic patients above 18 y

Brief summary: Asthma control study 2011


Eligibility criteria: Inclusion Criteria:

* Asthmatic patients above 18 y

Exclusion Criteria:

* COPD
* pulmonary cancer
* pulmonary tuberculosis

Primary outcomes:
measure: Asthma control level
timeFrame: 2 times
Secondary outcomes:
measure: Routine Therapeutical habits in control maintenance
timeFrame: 2 time
Other outcomes:
Locations:
city: Adásztevel
country: Hungary
facility: Research Site
city: Ajka
country: Hungary
facility: Research Site
city: Albertirsa
country: Hungary
facility: Research Site
city: Baja
country: Hungary
facility: Research Site
city: Balatonendréd
country: Hungary
facility: Research Site
city: Budajenő
country: Hungary
facility: Research Site
city: Budakeszi
country: Hungary
facility: Research Site
city: Budapest
country: Hungary
facility: Research Site
city: Békéscsaba
country: Hungary
facility: Research Site
city: Békés
country: Hungary
facility: Research Site
city: Celldömölk
country: Hungary
facility: Research Site
city: Dabas
country: Hungary
facility: Research Site
city: Debrecen
country: Hungary
facility: Research Site
city: Dombóvár
country: Hungary
facility: Research Site
city: Dunaújváros
country: Hungary
facility: Research Site
city: Edelény
country: Hungary
facility: Research Site
city: Eger
country: Hungary
facility: Research Site
city: Encs
country: Hungary
facility: Research Site
city: Esztergom
country: Hungary
facility: Research Site
city: Gyula
country: Hungary
facility: Research Site
city: Gyöngyös
country: Hungary
facility: Research Site
city: Győr
country: Hungary
facility: Research Site
city: Hatvan
country: Hungary
facility: Research Site
city: Hódmezővásárhely
country: Hungary
facility: Research Site
city: Kaposvár
country: Hungary
facility: Research Site
city: Kecskemét
country: Hungary
facility: Research Site
city: Kisbér
country: Hungary
facility: Research Site
city: Kiskunfélegyháza
country: Hungary
facility: Research Site
city: Kiskunhalas
country: Hungary
facility: Research Site
city: Komárom
country: Hungary
facility: Research Site
city: Körmend
country: Hungary
facility: Research Site
city: Lenti
country: Hungary
facility: Research Site
city: Miskolc
country: Hungary
facility: Research Site
city: Monor
country: Hungary
facility: Research Site
city: Mosdós
country: Hungary
facility: Research Site
city: Mátraháza
country: Hungary
facility: Research Site
city: Mór
country: Hungary
facility: Research Site
city: Nagykanizsa
country: Hungary
facility: Research Site
city: Nyíregyháza
country: Hungary
facility: Research Site
city: Paks
country: Hungary
facility: Research Site
city: Pécs
country: Hungary
facility: Research Site
city: Sopron
country: Hungary
facility: Research Site
city: Szarvas
country: Hungary
facility: Research Site
city: Szeged
country: Hungary
facility: Research Site
city: Szombathely
country: Hungary
facility: Research Site
city: Székesfehérvár
country: Hungary
facility: Research Site
city: Tatabánya
country: Hungary
facility: Research Site
city: Tata
country: Hungary
facility: Research Site
city: Tiszaújváros
country: Hungary
facility: Research Site
city: Törökbálint
country: Hungary
facility: Research Site
city: Törökszentmiklós
country: Hungary
facility: Research Site
city: Veszprém
country: Hungary
facility: Research Site
city: Zalaegerszeg
country: Hungary
facility: Research Site
Study officials:
affiliation: Semmelweis University Budapest Pulmonology Clinic
name: György Losonczy, MD PHD
role: PRINCIPAL_INVESTIGATOR
References: